Dynamic Technology Lab Private Ltd Invests $234,000 in Taro Pharmaceutical Industries Ltd. (TARO)

Dynamic Technology Lab Private Ltd purchased a new position in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 2,092 shares of the company’s stock, valued at approximately $234,000.

Other hedge funds also recently made changes to their positions in the company. Wells Fargo & Company MN grew its stake in shares of Taro Pharmaceutical Industries by 11.2% in the second quarter. Wells Fargo & Company MN now owns 1,685 shares of the company’s stock worth $189,000 after acquiring an additional 170 shares during the period. Bessemer Group Inc. grew its stake in shares of Taro Pharmaceutical Industries by 138.6% in the second quarter. Bessemer Group Inc. now owns 2,083 shares of the company’s stock worth $234,000 after acquiring an additional 1,210 shares during the period. Bank of Montreal Can grew its stake in shares of Taro Pharmaceutical Industries by 7.5% in the second quarter. Bank of Montreal Can now owns 2,128 shares of the company’s stock worth $238,000 after acquiring an additional 149 shares during the period. Highstreet Asset Management Inc. bought a new stake in shares of Taro Pharmaceutical Industries in the second quarter worth approximately $244,000. Finally, Russell Investments Group Ltd. grew its stake in shares of Taro Pharmaceutical Industries by 7.4% in the second quarter. Russell Investments Group Ltd. now owns 2,257 shares of the company’s stock worth $253,000 after acquiring an additional 156 shares during the period. Hedge funds and other institutional investors own 14.20% of the company’s stock.

A number of brokerages have recently commented on TARO. TheStreet upgraded shares of Taro Pharmaceutical Industries from a “c” rating to a “b-” rating in a research note on Thursday, July 20th. BidaskClub lowered shares of Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a research report on Sunday, July 16th.

COPYRIGHT VIOLATION WARNING: “Dynamic Technology Lab Private Ltd Invests $234,000 in Taro Pharmaceutical Industries Ltd. (TARO)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of US & international copyright law. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/11/01/dynamic-technology-lab-private-ltd-invests-234000-in-taro-pharmaceutical-industries-ltd-taro.html.

Shares of Taro Pharmaceutical Industries Ltd. (TARO) opened at 112.42 on Wednesday. Taro Pharmaceutical Industries Ltd. has a 12 month low of $92.28 and a 12 month high of $124.52. The company has a market capitalization of $4.55 billion, a price-to-earnings ratio of 11.45 and a beta of 0.65. The company’s 50-day moving average is $109.57 and its 200 day moving average is $110.43.

Taro Pharmaceutical Industries Company Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

What are top analysts saying about Taro Pharmaceutical Industries Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Taro Pharmaceutical Industries Ltd. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit